Pentazocine, sold under the brand name Talwin among others, is a painkiller used to treat moderate to severe pain. It is believed to work by activating (agonizing) κ-opioid receptors (KOR) and blocking (antagonizing) μ-opioid receptors (MOR). As such it is called an opioid as it delivers its effects on pain by interacting with the opioid receptors. It shares many of the side effects of other opioids like constipation, nausea, itching, drowsiness and a reduced effort to breathe, but unlike most other opioids it fairly frequently causes hallucinations, nightmares and delusions. It is also, unlike most other opioids, subject to a ceiling effect, which is when at a certain dose (which differs from person-to-person) no more pain relief, or side effects, is obtained by increasing the dose any further.
This report contains market size and forecasts of Pentazocine in global, including the following market information:
Global Pentazocine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pentazocine Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Pentazocine companies in 2021 (%)
The global Pentazocine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injections Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pentazocine include Teva, pfizer, Merck KGaA and LUPIN PHARMACEUTICALS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pentazocine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pentazocine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Pentazocine Market Segment Percentages, by Type, 2021 (%)
Injections
Tablets
Global Pentazocine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Pentazocine Market Segment Percentages, by Application, 2021 (%)
Adults
Children
Elderly
Global Pentazocine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Pentazocine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pentazocine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pentazocine revenues share in global market, 2021 (%)
Key companies Pentazocine sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Pentazocine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva
pfizer
Merck KGaA
LUPIN PHARMACEUTICALS